American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.40 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.38 per share a year ago.
Cogent Biosciences Inc. has described compounds acting as fibroblast growth factor receptor (FGFR) inhibitors reported to be useful for the treatment of achondroplasia, cancer, craniosynostosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback